NKLR

Terra Innovatum is a development-stage nuclear-reactor startup that October-2025 SPAC'd (via GSR III) and, in its own words, 'has not generated any revenue since inception' and does 'not expect to generate any revenue unless and until we are able to commercialize our reactors.' Commercial deployment of its SOLO micro-modular reactor is targeted for 2028, and it has only 'initiated regulatory engagement' with the NRC — meaning years of cash burn, licensing risk, and dilution stand between today and a first dollar of sales. This is a venture bet wearing a public ticker, not a stock with analyzable earnings.

The headline P/E of 0.5x on $9.74 diluted EPS is a data artifact, not value. The $540M 'net income' cannot be operating profit: operating income was -$33.7M and operating cash flow was -$10.3M. The gain is a non-cash accounting product of the recapitalization / preferred-share and warrant mechanics disclosed in the MD&A (bridge-loan conversions, 40.2M shares issued on preferred conversion, PIPE at $10.00). Strip it out and you have a company that lost money at every real line and is guiding to larger losses: management explicitly 'expect[s] that operating losses and negative cash flows will increase in the coming years.'